Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Culturally-targeted Communication to Promote SARS-CoV-2 Antibody Testing in Saliva: Enabling Evaluation of Inflammatory Pathways in COVID-19 Racial Disparities

NCT04957082 is registered in ClinicalTrials.gov with Michigan State University as lead sponsor.

NCT NCT04957082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04957082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Culturally-targeted Communication to Promote SARS-CoV-2 Antibody Testing in Saliva: Enabling Evaluation of Inflammatory Pathways in COVID-19 Racial Disparities
Lead sponsor
Michigan State University
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2021
Completion date
December 19, 2022
Enrollment
666 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov2 infection